SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-054600
Filing Date
2022-02-25
Accepted
2022-02-25 17:04:26
Documents
12
Period of Report
2022-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d289527d8k.htm   iXBRL 8-K 24014
  Complete submission text file 0001193125-22-054600.txt   148913

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cmpx-20220222.xsd EX-101.SCH 2884
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmpx-20220222_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmpx-20220222_pre.xml EX-101.PRE 11726
6 EXTRACTED XBRL INSTANCE DOCUMENT d289527d8k_htm.xml XML 3465
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39696 | Film No.: 22681646
SIC: 2836 Biological Products, (No Diagnostic Substances)